BioCentury
ARTICLE | Clinical News

AGT-181: Preliminary Ph I/II AGT-181-101 data

April 27, 2017 9:09 PM UTC

In February, ArmaGen reported preliminary data from 5 children ages ≥2 with Hurler syndrome who had previously received enzyme replacement therapy (ERT) in stage 2 of the open-label, dose-escalation, ...

BCIQ Company Profiles

ArmaGen Inc.